With Zheng Li absent, only Cheng Gang went to the meeting in Yanjing in his place.
In the past two years, I've participated in quite a few remote video conferences held in Beijing.
However, only a small number of people actually participate offline.
Especially since only one company, Kechuang Bio, participated, it seems to be the first time.
Previously, the company licensed its endorphin patents to external parties, partly because the production capacity of Kechuang Biotechnology could not keep up with the demand.
The production of endorphins requires highly skilled operators, involves a long cultivation period, and requires a long time to expand production capacity.
Secondly, due to the prevailing circumstances at the time, the government hinted that Kechuang Bio should license its endorphin patent to external parties, at least to domestic pharmaceutical companies, who would then pay the patent licensing fees.
Therefore, Kechuang Bio simply licensed its technology to biopharmaceutical companies worldwide, allowing them to produce endorphins as long as they paid the fee.
It was precisely because of this move by Kechuang Bio back then that America always felt that Kechuang Bio was a potential target.
Therefore, at most, the company will be placed on the watch list, without any direct sanctions.
Even if Kechuang Bio makes revolutionary progress in lithium battery technology, America will still not impose sanctions.
Because the top lithium battery manufacturers are all located in East Asia, including CATL and BYD from China, Panasonic from Japan, and LG and Samsung from South Korea.
America has no involvement in the lithium battery manufacturing industry.
If Kechuang Biotechnology develops semiconductors or artificial intelligence, it will inevitably face sanctions.
"Come on, Mr. Cheng, this is our first time meeting. We mainly wanted to talk to you about the development of Kechuang Bio in recent years and your future plans."
"Leadership, Kechuang Bio is currently primarily a technology research and development company. Especially after developing brain-computer interface technology, we have determined this path and operate the company through technology research and development patent licensing."
We will continue to increase investment in research and development, focusing on our two main pillars: biomedicine and brain-computer interfaces.
"So what's going on with this lithium battery? It doesn't seem to fall under the category of biomedicine."
"Boss, the lithium battery technology is a project that our chairman Zheng Li personally oversees at the Lion City R&D Center."
I don't know if you're aware, but Zheng Li is the founder of Kechuang Biotechnology, and also the main inventor of brain-computer interfaces and endorphins.
“I’ve heard about him. He’s a talented young man. I really want to meet him, but unfortunately he’s still in Singapore. However, since that incident, we’ve been asking our colleagues at the embassy to keep a close eye on the safety of overseas Chinese.”
Indeed, after the Singapore Research and Development Center of Sci-Tech Biotech was hacked, the number of military attachés at the Singapore Chinese Embassy increased significantly.
"We are very grateful for the country's continued support for Kechuang Biotechnology. This lithium battery technology also comes from the scientific research and innovation of our chairman."
Mr. Zheng has a background in mathematics, and even after he devoted himself to research and development in the field of biomedicine, he never gave up his study of mathematics.
In fact, the brain-computer interface technology developed by Kechuang Bio is essentially an advancement in mathematics, which involves noise reduction processing of human brainwave signals.
Our biggest advantage over other brain-computer interface manufacturers lies in our more advanced algorithms, which process brainwave signals so that they can be accurately recognized by computers.
The essence of this lithium battery technology innovation is also mathematics. Chairman Zheng himself is interested in the new energy industry. When he was reading the literature, he realized that the structure of lithium metal could be optimized.
Therefore, Mr. Zheng optimized the structure of lithium metal by combining a certain topological structure in mathematics, which led to the current results.
Since I've long forgotten my math skills, I don't remember exactly which topological structure inspired Mr. Zheng.
When Cheng Gang was pursuing his doctorate, biocomputation wasn't popular yet, and the mathematical requirements were nowhere near as high as they are now. Furthermore, Cheng Gang has been away from the forefront of scientific research for so many years; he's probably forgotten most of his undergraduate calculus, let alone topology.
"Haha, I totally understand. But I have a question: how does the cost of Kechuang Bio's lithium battery technology compare to the current mainstream cathode materials? How is its safety?"
"It is safer than the current mainstream cathode materials. We have improved stability through unique graphene materials. The cost is expected to be about 20% to 30% higher than the current mainstream products."
As production capacity increases, costs will decrease.
Cheng Gang's answer surprised the other party. The range they could accept was double the price, even if it was double the price of the current cathode material, they would still increase subsidies to promote it.
"Very good, you did a great job."
China's industrial upgrading relies on continuous technological innovation, and in this respect, Kechuang Bio truly deserves its reputation as a leader on the Science and Technology Innovation Board.
Furthermore, this is a rare opportunity to drive industry progress. Are you planning to use patent licensing or build your own factory this time?
"In the early stages, we will only grant patent licenses to companies within China."
“Very good. It’s a good thing that you have the desire to support the progress of China’s industries. We will also provide support for science and technology innovation and biotechnology at the government level.”
Furthermore, if you grant patent licenses to all battery manufacturers, then I hope that Kechuang Biotechnology can take the lead in promoting the battery swapping standard.
In 2022, China's central bank held a massive amount of cash, waiting to inject liquidity to offset the impact of the Federal Reserve's interest rate hikes.
Therefore, from the beginning to the end of the year, there has been talk of investing money in the new infrastructure sector. As for what the new infrastructure is, it includes areas such as data processing, 5G base stations, big data centers, and new energy vehicles.
My dear reader, there's more to this chapter! Please click the next page to continue reading—even more exciting content awaits!
Continue read on readnovelmtl.com
